Company Filing History:
1 out of 1,743 
1 out of 5,076 
1 out of 230 
Years Active: 2015
Title: Sangkon Oh: Innovator in Antibody Research
Introduction
Sangkon Oh is a notable inventor in the field of antibody research. He has made significant contributions to the understanding and treatment of autoimmune and inflammatory conditions. His work focuses on developing innovative therapeutic approaches that harness the power of antibodies.
Latest Patents
Sangkon Oh has developed several important patents, including "Anti-Cd40 Antibodies And Uses Thereof." This patent describes an antibody or an antigen-binding fragment that binds to CD40, featuring specific sequence identities for both light and heavy chain variable regions. Another significant patent is "Methods And Compositions For Treating Autoimmune And Inflammatory Conditions." This patent outlines methods for inhibiting inflammatory or autoimmune responses and inducing immune tolerance through the use of APC-targeted antibodies linked to IL-10.
Career Highlights
Throughout his career, Sangkon Oh has worked with prestigious institutions such as Baylor Research Institute and Inserm. His research has focused on advancing the understanding of immune responses and developing novel therapeutic strategies.
Collaborations
Sangkon Oh has collaborated with esteemed colleagues, including Jacques F. Banchereau and Gerard Zurawski. These collaborations have further enriched his research and contributed to the advancement of antibody therapies.
Conclusion
Sangkon Oh's innovative work in antibody research has the potential to significantly impact the treatment of autoimmune and inflammatory disorders. His contributions to the field are noteworthy and continue to inspire future research endeavors.